Sudarshan Pharma Industries Ltd — Important, 18-05-2026: Company Update

Sudarshan Pharmachem has announced a board meeting, pre-poned to Thursday, 21st May 2026. The board will consider and approve the migration of the company's equity shares from the BSE SME Platform to the Main Boards of both BSE and NSE. This strategic move, which requires shareholder approval, aims to enhance liquidity and visibility for investors. The meeting will also discuss approving the application for NSE main board listing and the Postal Ballot Notice to seek shareholder consent for these key changes.